Results 151 to 160 of about 4,889,938 (291)

Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice [PDF]

, 2005
Mitsuharu Yoshiyama
openalex   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Angiotensin II to Treat Intraoperative Vasoplegic Shock in an Infant. [PDF]

J Med Cases
Shamansky N, Willer B, Argote-Romero G, Tobias JD.   +3 more
europepmc   +1 more source

Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium [PDF]

, 1993
Akira Ishihata, Masao Endoh
openalex   +1 more source

Angiotensin II

Springer Reference Medizin, 2019
Stephanie Carmon, Nikki Matos, Rebecca Burnside, P. Moreno, Franco, Devang Sanghavi, J. Peters, D. Buchnea   +7 more
semanticscholar   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Estradiol is not protective against angiotensin II-induced hypertension in middle-aged ovariectomized rats. [PDF]

Physiol Rep
Leite APO, Pires Dos Santos I, Zha Y, Blessinger SA, Petillo H, Jasti N, Cheeran HC, Menon R, Walker AB, Daniel JM, Lindsey SH.   +10 more
europepmc   +1 more source

Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure [PDF]

, 2000
Toshiyuki Matsumoto, Ryoji Ozono, Tetsuya Oshima, Hideo Matsuura, Taijiro Sueda, Goro Kajiyama, Masayuki Kambe   +6 more
openalex   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers. [PDF]

Int J Mol Sci
Chatzipieris FP, Mavromoustakou K, Matsoukas JM, Mavromoustakos T.   +3 more
europepmc   +1 more source